CERS News and Press, Cerus Corporation From 06/17/20

Carver Bancorp (NASDAQ: CARV ) +232% . More news on: Carver Bancorp, Inc., Urban One, Inc., Energous Corporation, Stocks on the move, , Read more ...

Pandemic related shortages highlight importance of blood donations Cerus Corporation (Nasdaq:CERS) celebrates World Blood Donor Day this Sunday, June 14, 2020. Enacted by the World Health Organization (WHO), World Blood Donor Day highlights the need for safe blood and safe blood produ...

PMA-S includes submission for pathogen-reduced cryoprecipitate-poor plasma Cerus Corporation (Nasdaq:CERS) announced today that the Company has submitted a pre-market approval supplement (PMA-S) to the FDA for a pathogen reduced cryoprecipitated fibrinogen complex with 5-day post thaw ...

Cerus Corp. (CERS) has been one of my favorite COVID-19 tickers for a number of reasons. First and foremost, the company's INTERCEPT system is one of the world's leading blood safety devices and has already proven its efficacy against other coronaviruses. In addition, Cerus' INTERCEPT is posit...

Image source: The Motley Fool. Cerus Corporation   (NASDAQ: CERS) Q1 2020 Earnings Call May 5, 2020 , 4:30 p.m. ET Operator Continue reading

Cerus Corporation (CERS) Q1 2020 Earnings Conference Call April 5, 2020 04:30 PM ET Company Participants Tim Lee - Investor Relations Obi Greenman - President and Chief Executive Officer Kevin Green - Chief Financial Officer Vivek Jayaraman - Chief Operating Officer Carol Moo...

Cerus (NASDAQ: CERS ): Q1 GAAP EPS of -$0.10 in-line. More news on: Cerus Corporation, Earnings news and commentary, Healthcare stocks news, Read more ...

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2020. Recent developments and highlights include: Total first quarter 2020 revenue of $24.6 million Quarterly product revenue of $18.6 million, a 6% increase compared to the ...

Stemline Therapeutics (NASDAQ: STML ) +151%  on Menarini bid . More news on: Stemline Therapeutics, Inc., Applied DNA Sciences, Inc., KLX Energy Services Holdings, Inc., Stocks on the move, , Read more ...

Cerus Corporation (Nasdaq:CERS) announced today FDA regulatory approval for manufacture of INTERCEPT plasma with a new, alternative plastic disposable kit. The planned conversion to these new kits is part of the Company’s ongoing strategy to enhance its global supply chain integrity th...